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ABSTRACT 
Testosterone production surges during puberty and orchestrates massive growth and 
reorganization of the prostate gland, and this glandular architecture is maintained thereafter 
throughout adulthood. Benign prostatic hyperplasia (BPH) and prostate adenocarcinoma (PCA) 
are common diseases in adulthood that do not develop in the absence of androgens. Our 
objective was to gain insight into gene expression changes of the prostate gland at puberty, a 
crucial juncture in prostate development that is androgen dependent. Understanding the role 
played by androgens in normal prostate development may provide greater insight into androgen 
involvement in prostatic diseases. Benign prostate tissues obtained from pubertal and adult age 
group cadaveric organ donors were harvested and profiled using 20,000 element cDNA 
microarrays. Statistical analysis of the microarray data identified 375 genes that were 
differentially expressed in pubertal prostates relative to adult prostates including genes such as 
Nkx3.1, TMEPAI, TGFBR3, FASN, ANKH, TGFBR2, FAAH, S100P, HoxB13, fibronectin, 
and TSC2 among others. Comparisons of pubertal and BPH expression profiles revealed a subset 
of genes that shared the expression pattern between the two groups. In addition, we observed that 
several genes from this list were previously demonstrated to be regulated by androgen and hence 
could also be potential in vivo targets of androgen action in the pubertal human prostate. 
Promoter searches revealed the presence of androgen response elements in a cohort of genes 
including tumor necrosis factor-α induced adipose related protein, which was found to be 
induced by androgen. In summary, this is the first report that provides a comprehensive view of 
the molecular events that occur during puberty in the human prostate and provides a cohort of 
genes that could be potential in vivo targets of androgenic action during puberty. 
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uring prenatal development, the prostate gland falls into a quiescent phase at the third 
trimester of pregnancy due to a drop in testosterone levels. This dormant phase persists 
until puberty when the testosterone level surges and the prostate doubles in size and 
acquires the ability to produce secretions (1). The prostate undergoes dramatic morphologic 
changes as the epithelial cells proliferate and change from stratified to cuboidal, while glands 
branch and acini spread, giving rise to the complex glandular architecture seen in the adult 
prostate. The morphologic and functional changes follow complex reprogramming of the 
prostate cells that involves alterations of the cytoskeleton and extracellular matrix and changes in 
downstream signaling pathways that are poorly understood (2, 3). Normal puberty is associated 
with the onset and progressive activation of the hypothalamic-pitutary-gonadal axis and the 
resultant development of secondary sexual characteristics. This is achieved by increases in 
gonadotropin releasing hormone (GnRH), luteinizing hormone (LH), and the sex steroids 
testosterone and dihydrotestosterone (DHT), to control a wide variety of processes during 
puberty including prostate development. Androgens are important regulators of male sexual 
differentiation, including their essential role in directing the development of male accessory sex 
organs such as the prostate (4, 5). Androgen binding to its receptor leads to the assembly of 
activated transcriptional complexes at androgen response elements (AREs) of target gene 
promoters under the tight regulation of co-activators and co-repressors (6). Understanding the 
gene expression pattern of the androgen-dependent changes in the normal human prostate until 
now has largely been dependent on histologic studies (7). cDNA microarray analysis can be used 
to study the expression of thousands of genes simultaneously and is an important tool to advance 
biological discovery (8). Three recent studies examined the temporal changes in the global gene 
expression profile in prostate cancer derived cell lines using cDNA microarrays in response to 
the synthetic androgen R1881 and or DHT (9–11). These studies identified numerous genes 
regulated by androgens in androgen responsive human prostate epithelial cancer cell lines. The 
androgen response in human prostate stromal cells and penile foreskin fibroblasts was also 
analyzed (12). These studies have been limited in their scope due to use of cell culture models. 
The effects of androgens have been extensively studied in prostate models because of the 
relationship between androgens and the development of widely prevalent neoplastic diseases of 
the prostate such as benign prostatic hyperplasia (BPH) and prostate adenocarcinoma (PCA). 
Metastatic PCA regresses with inhibition of androgen production and or blockade of the 
androgen receptor until androgen-independent transformation occurs. Within the prostate, the 
enzyme 5-α reductase converts testosterone to the more potent DHT. Inhibition of this activity of 
the enzyme by the drug finasteride has been shown to decrease the symptoms related to BPH 
(13, 14). Interestingly, finasteride has recently been implicated as a drug that may possibly 
prevent the development of PCA (15). 
Our objective was to characterize the temporal gene expression pattern of the normal human 
prostate during puberty in a global fashion using cDNA microarrays. This important stage of 
prostate development occurring during puberty is controlled by the key hormones testosterone 
and DHT. By identifying the targets of androgen action in vivo in the normal developing 
prostate, we may gain insight into the pathophysiology of common androgen-dependent 
neoplastic diseases. 
D 
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MATERIALS AND METHODS 
Tissue collection and processing 
In this study, whole prostates and bladders were collected from cadaveric organ donors at the 
time of transplant organ harvest. This resource was chosen because it provided a source of whole 
intact specimens that could be processed quickly enough to perform RNA-based studies. The 
study proceeded with the approval of the Institutional Review Board and the Michigan 
Transplantation Society. Between July 2001 and present, the University of Michigan Transplant 
team harvested organs for cadaveric transplant from nine brain dead male organ donors for 
whom consent to collect research tissue was authorized. Three of the nine donors had a physical 
appearance consistent with Tanner stage II or III and were classified as pubertal. The remaining 
six donors appeared to be Tanner stage V and were classified as adults. Immediately after harvest 
of transplantable organs, we retrieved the prostate and bladder intact (approximately within 30-
60 min of aortic clamping) and preserved the specimens on ice until return to our institution 
(~10-90 min). The prostates were immediately processed as radical prostatectomy surgical 
specimens. The majority of prostate tissue was placed in OCT, flash frozen in liquid nitrogen, 
and stored at –80°C until RNA extraction. RNA was extracted using TRIzol reagent according to 
the instructions of the manufacturer (Gibco-BRL, Rockville, MD). Integrity of RNA was 
assessed with denaturing agarose gel electrophoresis. Sections from the transition and peripheral 
zones were dissected, prepared separately, and hybridized as two specimens from the prostate of 
the 21 year old. For the purposes of analysis, these were considered as two separate adult 
specimens. In the remaining cases, a representative section from the mid-gland comprised of 
both peripheral and transition zone tissues was used. Remaining prostate tissue was formalin-
fixed and subsequently paraffin embedded. Collecting tissues at the time of organ donation 
provided the advantage of retrieving whole intact prostate for the sole purpose of our studies. 
The rapid tissue processing after aortic clamping minimized RNA degradation compared with 
autopsy-acquired tissue. At the time of harvest, serum samples from the organ donors were 
collected. These were subsequently used to obtain serum testosterone and PSA measurements 
using a competitive immunoassay technique (Ortho-Clinical Diagnostics, Rochester, NY). 
Microarrays and hybridization 
Microarrays (20K chip) containing sequence verified PCR-amplified human cDNAs representing 
15,495 Unigene clusters were manufactured as described previously (16) with minor 
modifications. The clone information can be obtained from our lab web site 
(http://www.pathology.med.umich.edu/chinnaiyan/index.html). Protocols for printing and 
postprocessing of arrays are available (http://www.microarrays.org/protocols.html). cDNA 
microarray analysis of gene expression was done essentially as described previously (16). 
Briefly, total RNA isolated from prostate tissues was ensured for quality by denaturing agarose 
gel electrophoresis. The RNA was then reverse transcribed and labeled with cy5 fluorescent dye. 
The control human prostate total RNA was obtained from a commercial source (Clontech, Palo 
Alto, CA) and prepared in a similar fashion and labeled with cy3 fluorescent dye. The labeled 
products were then mixed and hybridized to a 20K cDNA array. The images were flagged and 
normalized using the Genepix software package (Axon Instruments Inc., Union City, CA). Data 
were median-centered by arrays and only genes that had expression values in at least 80% of the 
samples were used in the analysis. 
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Statistical analysis of microarrays 
The normalized data set from each experiment was log transformed, filtered for bad spots, and 
median centered before it was subjected to statistical analysis of microarrays (SAM) as described 
previously (17, 18). The SAM analysis compared the expression profiles of the pubertal to the 
adult prostates. The significant genes from the SAM analysis were then clustered by 
implementing an average linkage hierarchical clustering and the output visualized with Tree 
View software (19). 
Histology and immunohistochemistry 
Paraffin embedded prostate tissue blocks were sectioned and stained with hematoxylin and eosin 
(H&E). Immunohistochemical staining was performed with polyclonal goat anti-androgen 
receptor antibody (Santa Cruz Biotechnology, Santa Cruz, CA) at 1:1000 dilution using standard 
indirect biotin-avidin technique. Slides were reviewed by an experienced genito-urinary 
pathologist (MAR). 
Real-time quantitative PCR and RT-PCR 
To validate microarray results, we performed quantitative real-time PCR (QPCR) for S100P and 
TMEPAI expression using SYBR green as described previously (20). Briefly, total RNA was 
reverse transcribed into first-strand cDNA. The quantity of cDNA in each sample was calculated 
by interpolating its Ct value vs. a standard curve of Ct values obtained from serially diluted 
cDNA from commercially available pooled normal prostate samples (Clontech) and one of the 
prostate cancer samples. The calculated quantity of S100P or TMEPAI for each sample was then divided 
by the quantity of the housekeeping gene glyceraldehyde-3 phosphate dehydrogenase (GAPDH) 
corresponding to each sample to give a relative expression of S100P or TMEPAI for each sample. Primer 
sequences 5′-3′ were as follows: TMEPAI forward: CCTTCTCTTCCCCTTTCCATCTCC, TMEPAI 
reverse: GTCCCGCCAACCCCAAATCTATCT; S100P forward: CGAGGGCAGCACGCAGACC, 
S100P reverse: GAGCAATTTATCCACGGCATCCTT. GAPDH primers were as described previously 
(21). Another control gene hydroxymethylbilane synthase (HMBS) showed a similar pattern to GAPDH 
expression (data not shown). RT-PCR was performed as described previously (17). The primer sequences 
for TIARP are as follows: TIARP forward: AGCAAAGCCAAGCAAAGAGTGATG, TIARP reverse: 
CAGCAGACAAATAGAAGGGGAACC. The amplification was carried out for 28 cycles at 55°C as 
the annealing temperature. 
Meta-analysis 
Androgen data set 
The microarray data set for androgen-treated LNCaP cells described by DePrimo et al. (11) was 
downloaded from Stanford Microarray Database. We selected 9791 mRNA transcripts that had 
data of sufficient quality (regression correlation >0.6) in at least three of the four androgen 
profiles and in at least one of the ethanol profiles. Transcripts in the LNCaP data set were then 
ranked, from highest to lowest, by their average ratios across the androgen profiles, minus their 
average across the ethanol control profiles. Selecting 18,144 transcripts from our profile data set 
of pubertal and adult prostate tissues with quality data in at least two of the three pubertal 
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profiles, we ranked these transcripts, from highest to lowest, by their average ratios across the 
adult profiles minus the average ratio across the pubertal prostate profiles. The two ranked gene 
lists (androgen treatment and adult vs. pubertal prostate) shared 8752 transcripts delineated by 
common unique clone identifiers. The significance of shared overlap between the genes most 
highly induced by androgen in LNCaP cells and genes most highly up-regulated in adult over 
pubertal prostates was assessed using the one-sided Fisher’s exact test, where the top genes from 
each ranked gene list ranged from 1 to 1000. 
BPH data set 
From the list of pubertal signature genes from SAM analysis, we selected genes that were 
differentially expressed in our BPH samples (16, 22). We performed two sample t test between 
BPH and normal adult group. The genes were then tested on microarray data of Luo et al. (23, 
24) using clone ID as cross-reference. For the data set of Luo et al., genes that had expression 
values in <80% of the samples were excluded. 
Identification of ARE motifs 
Reference sequences of 360 genes were obtained from the Ref_Seq database at NCBI and used 
to query the UCSC genome assemblies (http://genome.ucsc.edu/), July 2003 (Human). Each 2 kb 
upstream sequence was scanned with the predefined high-quality ARE matrix by using MATCH 
program integrated in TRANSFAC Professional Suite (http://www.cognia.com). The matched 
sequence elements with false positive <0.1 were reported for each gene. If more than one 
putative element was identified, the motif mapping nearest to the 5′ end of the reference 
sequence was selected. All of the putative ARE motifs were aligned by using the CLUSTALW 
program (http://www.ebi.ac.uk/clustalw/). The sequence logos representing the ARE consensus 
sequences were generated by the online WEBLOGO program (http://weblogo.berkeley.edu). 
RESULTS 
The morphology of the pubertal prostate is distinct from adult prostate 
The clinical details of the cadaveric transplant organ donors are given (Table 1). The pubertal 
group was comprised of three donors, one aged 9 and two aged 13 years. There were external 
signs of pubertal onset in these donors, and this was assessed by the external appearance of the 
genitalia and the distribution of body hair at the time of organ harvest and staged according to 
the Tanner classification (25). The low serum testosterone levels from these donors were 
consistent with the developmental stage (Table 1). The adult group consisted of six individuals 
with an age range from 19-57 years. The causes of brain death were sudden and not related to 
any genitourinary conditions. The sections of prostate tissue were examined for glandular 
architecture after H&E staining. Histology identified the pubertal tissues to have fewer and less 
differentiated glands (Fig. 1A). Less epithelial branching was observed in the pubertal group 
when compared with the adults (Fig. 1B). As would be expected, the three pubertal donors had 
low serum PSA levels (Table 1). 
Androgen receptor staining (Fig. 1C and 1D) demonstrated that AR is present in both the stromal 
as well as the epithelial compartments of both groups; however, it exhibited differences in 
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cellular localization. The staining in epithelial cells of the pubertal group was more diffuse, 
probably due to the distribution of this receptor being predominantly cytoplasmic (Fig. 1C), 
while mainly nuclear in the adults (Fig. 1D). The androgen receptor protein has previously been 
shown to be expressed in both stromal as well as the epithelial cell types in prostate (26, 27) and 
cellular localization of the unliganded receptor in transfected cell lines was predominantly 
cytoplasmic (28). 
Gene expression profile of the pubertal prostate 
Microarray analysis was performed using total RNA isolated from the frozen prostate sections 
that had been analyzed by H&E staining. The labeled cDNA probes prepared from each total 
RNA sample were hybridized to a human 20K chip, which is similar to the chip described earlier 
(16). The normalized composite data set prepared from all hybridizations was used in SAM (18). 
This analysis (pubertal vs. the adult samples) yielded a list of 375 statistically significant genes, 
and the genes were also filtered to have a twofold or above difference in value between the two 
groups. The genes were analyzed using Cluster (19), implementing average linkage hierarchical 
clustering, and the output was visualized by TreeView (Fig. 2). The genes displayed in red and 
green colors represent over and underexpression, respectively, of a given gene compared with 
the employed reference RNA. The pubertal prostate samples formed a separate cluster owing to 
their gene expression differences from the adult prostate. Of the 375 genes, we found 131 genes 
to be up-regulated in the pubertal group while 244 were down-regulated. To confirm the gene 
expression pattern by an independent method, we performed QPCR for two genes. These were 
S100P, a calcium binding protein (29), and TMEPAI, also known as PMEPAI, a transmembrane 
androgen-induced protein (30) (Fig. 3). The Q-PCR values showed a pattern similar to 
microarrays for both genes. Additionally, we tested two genes, CEBPB and CEBPD, which were 
up- and down-regulated in pubertal tissues, respectively. We confirmed this pattern by 
semiquantitative RT-PCR (data not shown). 
The differentially expressed genes (Fig. 2) could be classified into several functional groups. 
Genes involved in fatty acid metabolism such as fatty acid synthase (FASN) and fatty acid amide 
hydrolase (FAAH); stress response genes like thioredoxin reductase, glutathione synthetase, and 
NDRG3; and growth factors and their receptors like CYR61, VEGF, and TGF-β receptors type II 
and type III (TGFBR2 and TGFBR3). TGF-β growth factor and receptor have previously been 
shown to be down-regulated by androgen and up-regulated by castration in murine prostate (31, 
32). In the present study, TGFBR2 and TGFBR3 were up-regulated in the pubertal prostates. To 
better understand the contribution of the stromal fibroblasts to the expresssion profile of the 
pubertal prostates, we compared our data to a recent study documenting the gene expression 
signature of androgen receptor dependent fibroblasts derived from urogenital mesenchyme (12). 
The comparison revealed that genes such as laminin A4, T-box5,3, fibronectin, nidogen, 
aldehyde dehydrogenase, TIMP1, tenascin (TNXB), fibulin, platelet derived growth factor-α 
(PDGFRA), and SPARC were highly expressed in genital foreskin fibroblasts and the pubertal 
prostates. Therefore, the presence of these genes could have reflected the stromal contribution to 
the expression profile of the pubertal prostates. Genes such as EPS8, S100P, LPL, Mal, 
Crystallin gamma, ITM2A, and α-2 macroglobulin (A2M) were found be underexpressed in the 
fibroblasts (12) but were highly expressed in the pubertal prostate, implying that the presence of 
these genes within the pubertal prostates was a contribution from the epithelial compartment. 
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Androgen-regulated genes in pubertal prostate 
Several studies have documented the transcriptional regulation of various genes mediated by 
androgen using DNA microarrays including our own unpublished data (9–11). The statistically 
significant genes in the SAM analysis were compared with the published data of androgen 
responsive genes (ARGs). Several of these were found to be common (Table 2). Genes such as 
TMEPAI, NKx3.1, FASN, and ankylosis homologue (ANKH) have been previously confirmed 
as ARGs by independent studies using different techniques (9, 10, 30, 33) and were 
underexpressed in pubertal prostate. Putative AREs have been identified in the promoter regions 
of these genes while genes like S100P, lipoprotein lipase (LPL), crystallin gamma (CRYG), 
A2M and clusterin were known androgen-repressed genes and were found to be up-regulated in 
the pubertal samples. We compared our pubertal data set with the available androgen-induced 
gene expression study performed on LNCaP cells (11). A statistically significant correspondence 
exists (Fig. 4A and 4B) between the genes induced by androgen in the cell line and genes 
underexpressed in pubertal prostate tissues (P<10E-25, by Fisher’s exact, for the overlap 
between the top 500 genes from each data set) demonstrating the in vitro system of androgen 
induction as a good model for in vivo behavior. A list of the top 40 genes that were both 
underexpressed in pubertal and overexpressed in LNCaP cells treated with androgen is displayed 
(Fig. 4C). In addition, we searched up to 2 Kb upstream of the transcription start site for 360 
reference sequences corresponding to the significant genes from our analysis with a predefined 
high-quality ARE matrix by using the MATCH program integrated in TRANSFAC Professional 
Suite. The program identified promoters of 52 genes to possess a putative ARE. The alignment 
of identified AREs and the consensus ARE sequence is shown (Fig. 5). A few of these genes 
were tested for androgen regulation by performing RT-PCR with gene specific primers on RNA 
isolated from the LNCaP prostate cell line treated with the synthetic androgen R1881 along a 
time course. The gene TMEPAI, present among the shortlisted genes from our study and 
previously demonstrated to be up-regulated by androgen, was used as a positive control for 
androgen response in our system. Primers designed for TIARP amplified a specific product and 
revealed it also to be up-regulated by androgen in treated LnCaP cells (Fig. 5). A TNF-α 
inducible 470 amino acid protein termed TIARP has six transmembrane regions, a large N 
terminus, and a short carboxy-terminal tail, a structure reminiscent of channel and transporter 
proteins. TIARP has been hypothesized to play a role in adipocyte development and metabolism 
(34). 
BPH and other prostate disease states 
Corresponding expression values for the 375 SAM selected genes were queried against our 
prostate cancer 20K cDNA microarray data set (www.oncomine.org) This data set consisted of 
19 BPH, 23 localized PCA, and 8 metastatic prostate cancer (MET) samples. We found three 
regions of similarity between the pubertal and BPH samples (Fig. 6), two of which were up-
regulated (Fig. 6A and 6B) and one down-regulated (Fig. 6C). The subset of common up-
regulated genes included TGFBR2 and TGFBR3. IGF II, which is synthesized and secreted by 
stroma (35), was found to be up-regulated in pubertal prostates. Expression of laminin β1 has 
been localized to basal cells (36). To further explore the gene expression similarity observed 
between pubertal and BPH samples, we compared pubertal signature genes to our BPH data set 
(present study) and an independent BPH gene expression data set previously reported by Luo et 
al. (23, 24) (Fig. 7). Among the 375 statistically significant genes from SAM analysis, we found 
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197 genes to be differentially expressed in our BPH samples compared with normal adult tissues 
by two sample t test (P<0.05, one-side). These 197 genes were then tested on data set of Luo et 
al. (23, 24) using clone ID as cross-reference. We found that 73 out of 129 available genes in 
their data were also differentially expressed in the nine BPH samples they profiled (against 25 
normal samples, one-sided t test, P<0.05). Laminin A4 and A2M, laminin β1, and epidermal 
growth factor receptor substrate 8 (EPS8) are up-regulated in pubertal prostate and have been 
shown to be overexpressed in our BPH data set and the previously reported BPH microarray 
profile (23, 24). Previously demonstrated androgen-regulated genes like VEGF, TPD52, and 
ANKH were underexpressed in pubertal prostates and BPH specimens. 
DISCUSSION 
We examined gene expression changes occurring during human prostate development at puberty 
by comparing microarray analyses from pubertal and adult prostates. This revealed that pubertal 
prostates possessed a distinct gene expression signature. This unique gene expression signature 
could be attributed to several characteristics of the prostate during puberty. The gene expression 
differences observed between the pubertal and adult prostate may account for the difference in 
cell type representation between the two stages of prostate. Shapiro et al. (7) has previously 
reported the changes in cellular composition of the prostate during various stages of 
development. They described inversely related age-dependent change in smooth muscle and 
connective tissue. Although there was a progressive increase in connective tissue until puberty 
and a decline thereafter, the smooth muscle declined thoroughout childhood until puberty and 
increased in adolescence and early adulthood. Morphologically there was a lower smooth muscle 
to connective tissue ratio within the stromal compartment of pubertal prostate compared with the 
adults (7). However, the stromal to epithelial ratio remained constant. Hence, one of the major 
factors influencing this gene expression profile could be the difference in cell type representation 
between the two stages. 
The second observation that we made was the link between androgen regulation of various genes 
and their expression pattern in the pubertal prostate. We confirmed that the pubertal prostates 
had low testosterone levels consistent with the physical appearance of the gland. Interestingly, 
we found high expression of S100P, crystallin gamma, and clusterin in pubertal prostates, which 
were described previously as androgen-suppressed genes. In addition, we found genes such as 
TMEPAI, NKx3.1, LPL, GLUD, IQGAP2, ANKH, and TPD52 were underexpressed in pubertal 
prostates, which were demonstrated in multiple previous studies to be up-regulated by androgen. 
Therefore, we hypothesized that amongst the pubertal prostate signature genes, a subset of genes 
could be potential in vivo targets of androgen. Recent work from our group suggests that TPD52 
is both amplified and androgen regulated in cancer but not the normal state (37). Studies revealed 
that androgen has a role in expression of the stress response genes in the prostate cancer cell 
lines (10). We observed that stress response genes such as thioredoxin reductase, glutathione 
synthetase, and NRDG3 were down-regulated in the pubertal prostate compared with adult 
prostates, indirectly raising the possibility for a role in the stress response for androgen. We also 
analyzed the promoters for 375 genes up to 3 Kb, in search of putative ARE. We identified 52 
genes that had one or more AREs in their promoter sequence. We tested a few genes for 
androgen regulation in LNCap cells. TMEPAI was used as a positive control in RT-PCRs, and it 
showed an induction of its message with androgen treatment as reported earlier. 
TIARP/FLJ23153, a six transmembrane protein that was selected for RT-PCR analysis, was also 
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induced by androgen. This transcriptional control unknown previously for TIARP is reported 
here for the first time. It is noteworthy that a previous study of androgen receptor knockout 
(ARKO) mice demonstrated a decrease in number and size of adipocytes in mice lacking the 
androgen receptor. Hence our finding of TIARP induction by androgen and the earlier 
observation from ARKO mice imply a role for TIARP in androgen-mediated adipoctye function 
and development (5). We suggest that TIARP plays a role in androgen-mediated action at least in 
adipocytes. Further studies are required to understand the role of TIARP in the prostate and 
adipocyte. An intriguing recent finding demonstrated that factors secreted by adipocytes, 
including leptin can stimulate prostate cancer cell line proliferation (38). 
In our study, Hox B6 and Hox B13 were up- and down-regulated respectively in the pubertal 
prostates. Hox gene expression in development and neoplastic conditions of the prostate has been 
reported (4, 39, 40). Among the Hox family genes Hox A10, A13, B13, and D13 have been 
shown to be required for normal prostate morphogenesis in murine models. A double knockout 
of Hox B13 and D13 results in a severe defect in mouse ventral prostate development. 
Immunohistochemical staining against Hox B13 and D13 proteins showed the expression to be 
restricted to the epithelial compartment (41–43). Neural cell adhesion molecule 1 (NCAM1) has 
been identified as a target of Hox genes (44). In particular, studies in cell lines have shown that 
Hox C6 and Hox B9 increased NCAM1 promoter activity. In our study, pubertal tissues had an 
elevated expression of NCAM1, consistent with Hox-related prostate development in humans. 
We speculate that the stages of prostate development are related to the temporal expression of 
particular Hox genes. 
Nkx3.1 is a homeobox gene that has given rise to interest in prostate development as well as 
prostate cancer (45, 46). In murine studies, Nkx3.1 initiated prostate epithelial development as 
well as ductal outgrowth of epithelial glands and subsequent regulation of epithelial growth and 
secretory function. Interestingly, Nkx3.1 expression appeared to be one of the earliest responses 
to androgens (4). In tissue recombination studies, the mode of Nkx3.1 expression in the 
developing prostate was related to stromal-epithelial interaction. The recombination studies have 
shown that mesenchymal androgen receptors direct epithelial branching though paracrine action. 
Later in development androgen receptors within the epithelium are necessary for secretory 
function. In our study, the adult prostates overexpressed Nkx3.1 relative to the pubertal prostates, 
consistent with the androgen regulation of this gene. 
We also compared the pubertal prostate signature to other diseased prostate tissue profiles and 
observed that a subset of genes had a similar trend in expression between the pubertal and BPH 
specimens. We further narrowed down the genes in the overlap by including a previously 
reported BPH profile (23, 24) in our analysis. Future detailed analysis of the BPH data set will 
help in understanding the underlying process that has led to the shared gene expression profile 
observed between the pubertal and BPH samples. The stromal to epithelial ratio remains constant 
from birth to age 40 in nonhyperplastic glands and is similar to the ratios in tissues derived from 
asymptomatic and symptomatic BPH patients. However, there was a difference between pubertal 
and adult prostates in the percentage of smooth muscle and connective tissue that comprise the 
stromal compartment (7). Earlier findings suggested a “reawakening” of fetal processes in BPH 
(47). This was based on the observation that ontogenetic processes are recapitulated in the 
development of stromal nodules in BPH. In this context, the significance of the genes that 
contributed to the shared signature between BPH and pubertal tissues requires further study. 
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Stromal-epithelial interactions play an important role in prostate function and development and 
also in many prostate disease conditions (48, 49). Thus, orchestrated gene expression cascades 
that can be regulated by androgen may occur simultaneously in both the compartments during 
development. Several genes identified by this study (Fig. 2) may also play an important role in 
the stromal-epithelial interactions in prostate during puberty. The pubertal prostate samples that 
we analyzed were derived from donors whose testosterone had not yet reached mature adult 
levels to fully activate the androgen-dependent cascade. 
In summary, this study describes the transcriptome signature of the pubertal prostate. The 
observed gene expression changes may have derived from both the stromal and epithelial 
compartments. Many of the genes with altered expression during the pubertal process were also 
shown to be regulated by androgen. Further characterization of genes from this list could identify 
novel in vivo targets of androgen in the human prostate. Future studies will be aimed at resolving 
the role of shortlisted genes identified in this study and their complex relationships between 
androgen action and development. 
Supplementary information (DNA microarray data sets) will be available at the author’s web 
site: http://chinnaiyan.path.med.umich.edu/. 
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Table 1 
 
Clinical characteristics of organ donors used in this study 
Donor Age Racea Cause of Brain Deathb Tanner Stagec    Serum 
testosterone 
(ng/dl) 
Serum 
PSA 
(ng/dl) 
1 13 C CHI-trauma III 0.37 0.068 
2 9 AA ABI-drowning II 0.22 0.000 
3 13 C CHI-trauma III 0.24 0.198 
4 22 C SAH V 4.07 0.588 
5 57 C ICH V 7.04 0.845 
6 46 C ICH V 0.86 0.586 
7 21 AA GSW V 9.07 0.422 
8 45 C SAH V 2.05 1.46 
9 19 C ICH V 5.73 0.434 
aRace: Caucasian (C) or African-American (AA). bCause of brain death: anoxic brain injury (ABI); closed head injury (CHI); gunshot wound to head 
(GSW); intracranial hemorrhage (ICH); subarachnoid hemorrhage (SAH). cTanner criteria (22). 
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Table 2 
 
Expression of androgen regulated genes in pubertal prostate 
                                         Microarray data 
Mean fold change 
Reported androgen regulation in cell linesa 
Gene symbol Current study           A      B      C 
Northern datab 
 
AZGP1 −3.1   +  
CEBPD −3.7  +   
CHK −1.9  +   
ELL2 −2.7 + + +  
FAAH −2.2  +   
GUCY1A3 −2.7 + + +  
IQGAP2 −2.0 + + +  
LCP1 −2.6 + +   
NKX3-1 −10.6 + + + + 
PDE7A −2.7  +   
SEPP1 −2.0   +  
TMEPAI −5.4 + + + + 
TPD52 -2.7 +  + + 
TSC2 -3.0  +   
ANKH -3.3 + + + + 
S100P 3.8    – 
CLU 2.0    − 
LPL 2.2    − 
FN1 3.0 −    
+: Up-regulation, −: down-regulation; a refs 9, 10, 11; b refs  9, 11, 26, 30, 31. 
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Fig. 1 
 
 
Figure 1. Morphology and androgen receptor expression of pubertal and adult prostate. Histology of a 
representative pubertal (A) and adult (B) prostate tissue, respectively. Sections were stained with H&E and images were 
taken at ×100 magnification. Androgen receptor expression as assessed by immunohistochemical staining of pubertal (C) 
and adult (D) tissue respectively. Images were captured at ×400 magnification. E: epithelium; S: stroma; L: lumen. 
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Fig. 2 
 
                                                          
   
Figure 2. Gene expression profile of pubertal prostate. Pattern of expression for 375 genes selected by 2 class SAM 
analysis (18), visualized by Tree View (19). Red indicates upregulated genes, green indicates down-regulated genes, black 
stands for no change, while gray refers to data not available. Donor 7p, 7t stand for peripheral and transitional zones 
respectively from donor 7. The gene symbols are provided (HUGO nomenclature). P: pubertal; A: adult. 
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Fig. 3 
 
              
 
Figure 3. Confirmation of microarray results by quantitative real-time PCR. Normalized median of ratio gene 
expression values from microarrays (filled bars) are compared with the relative expression values obtained with 
quantitative real-time PCR (open bars) for the genes S100P (top) and TMEPAI (bottom). 
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Fig. 4 
 
              
 
Figure 4. Gene expression meta-analysis to identify putative androgen target genes. A) A high correspondence in 
shared genes upregulated in LNCaP dataset and down-regulated in pubertal prostate. Black line indicates observed overlap 
and gray line shows expected overlap by probability between the datasets. B) Statistical significance of the shared gene 
overlap. Arrow indicates nominal significance level at P < 0.05. C) Expression pattern of 40 genes shared between top 300 
pubertal genes (underexpressed in pubertal vs. adult prostate with mean-centered average less than -0.45) and the top 300 
LNCaP androgen genes (overexpressed in R1881-treated cells with mean-centered average >2). Genes highlighted in bold 
appear in Table 2, and those italicized appear in Fig. 5. 
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Fig. 5 
 
                                      
               
Figure 5. Identification of ARE motifs and androgen induction of TIARP. A) Putative human AREs identified by 
searching the 5′ regulatory regions of genes that are differentially regulated in pubertal prostate for a motif corresponding 
to the TRANSFAC ARE consensus sequence. A CLUSTALW alignment identifies highly conserved residues shaded in 
black. A consensus sequence generated by WEBLOGO displays frequency of each base in the consensus proportional to 
character height, with  height of entire stack adjusted to signify information content of sequences at that position.  
B) RT-PCR analysis for TIARP and TMEAPI genes on RNA isolated from LNCaP cells treated with synthetic
androgen R1881 across time points. – : Mock-treated cells; while +: androgen-treated cells. GAPDH amplification 
was used as an internal control. 
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Fig. 6 
 
                                            
Figure 6. Comparison of pubertal prostate signature genes with other prostatic conditions. Gene expression 
signature of pubertal prostate compared with profiles obtained from various other disease states of the prostate namely 
benign prostatic hyperplasia (BPH), clinically localized prostate cancer (PCA), and hormone refractory-prostate cancer 
(MET). Regions of interest are highlighted including coordinately up-regulated (A, B) and down-regulated (C) in both 
pubertal and BPH tissues. Graphs A, B, and C represent average normalized median of ratio values of genes that comprise 
the corresponding regions of interest (A, B, and C) indicated in the treeview representation. Red indicates upregulated 
genes, green down-regulated genes, black no change, and gray data not available. 
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Fig. 7 
 
                  
 
Figure 7. Gene expression pattern shared between pubertal prostate and BPH. Seventy three statistically significant 
genes that exhibited similar expression pattern in the pubertal prostate and 2 BPH datasets (23, 24). Red indicates 
upregulated genes, green down-regulated genes, black no change, and gray data not available. Gene symbols are provided 
(HUGO nomenclature). NAP: normal adjacent prostate; BPH: benign prostatic hyperplasia. 
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